Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.58 USD | -0.65% | -5.95% | -23.54% |
Evolution of the average Target Price on BioCryst Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering BioCryst Pharmaceuticals, Inc.
RBC Capital Markets | |
Jefferies & Co. | |
BofA Securities | |
Evercore ISI | |
Needham & Co. | |
Barclays | |
Oppenheimer | |
Piper Sandler | |
JPMorgan Chase | |
Cantor Fitzgerald | |
HC Wainwright | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- BCRX Stock
- Consensus BioCryst Pharmaceuticals, Inc.